| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $41.9M | — | +14.3% |
| Cost of Revenue | $10.8M | — | +13.6% |
| Gross Profit | $31.1M | — | +14.5% |
| R&D Expense | $14.7M | — | +3.1% |
| SG&A Expense | $10.4M | — | -5.3% |
| Operating Income | -$10.1M | — | +20.0% |
| Pre-tax Income | -$9.5M | — | +15.8% |
| Income Tax | $141K | — | +2.9% |
| Net Income | -$9.6M | — | +15.6% |
| EPS (Basic) | -$0.15 | — | +21.1% |
| EPS (Diluted) | -$0.15 | — | +21.1% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $17.6M | -10.2% | -48.9% |
| Short-term Investments | $85.4M | -10.1% | +1.3% |
| Accounts Receivable | $26.8M | +4.7% | +20.2% |
| Current Assets | $142.5M | -6.8% | -2.1% |
| Total Assets | $162.4M | -6.5% | -3.4% |
| Current Liabilities | $34.0M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$11.7M | — | -11.3% |
| Capital Expenditures | $700K | — | +33.3% |
| Investing Cash Flow | $9.6M | — | +225.3% |
| Financing Cash Flow | $85K | — | +201.2% |
| Free Cash Flow | -$12.4M | — | -12.3% |
| +75.2% |
| Total Liabilities | $38.4M | -15.6% | +48.6% |
| Stockholders' Equity | $123.9M | -3.2% | -12.8% |